Biotechnology Stock Movers: Medivation, Illumina, Regeneron Pharmaceuticals Inc, Spectrum Pharmaceuticals

Lakeway, TX -- (SBWIRE) -- 02/19/2013 -- Bestdamnpennystocks, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

Medivation, Inc.(NASDAQ:MDVN) is lower 0.45% and is trading at $50.95. Medivation, Inc. is a biopharmaceutical company focused on the rapid development of small molecule drugs to treat serious diseases for which there are limited treatment options.

How Should Investors Trade MDVN After The Recent Movement? Find Out Here

Illumina, Inc.(NASDAQ:ILMN) added 0.53% and is trading at $48.99. Illumina, Inc. (Illumina) is a developer and manufacturer of life science tools and integrated systems for the analysis of genetic variation and function. The Company provides a line of genetic analysis solutions, with products and services that serve a range of interconnected markets, including sequencing, genotyping, gene expression, and molecular diagnostics.

Is ILMN A Strong Buy After The Recent Strong Gains? Get Free Trend Analysis Here

Regeneron Pharmaceuticals Inc(NASDAQ:REGN) fell 3.49% and is trading at $159.17. Regeneron Pharmaceuticals, Inc. (Regeneron) is an integrated biopharmaceutical company, which discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.

Is REGN a Buying Opportunity After The Recent Plunge? Don’t Miss Out Our Latest Report Here

Spectrum Pharmaceuticals, Inc.(NASDAQ:SPPI) is lower 2.49% and is trading at $11.34. CSpectrum Pharmaceuticals, Inc. (Spectrum) is a biotechnology company with integrated commercial and drug development operations with a focus in hematology and oncology. In the United States, it markets two oncology drugs, ZEVALIN and FUSILEV and have two drugs, apaziquone and belinostat, in late stage development along with a pipeline of drug candidates.

How Should Investors Trade SPPI After The Latest Earnings Report? Find Out Here

About bestdamnpennystocks.com
Best Damn Penny Stocks’ team is engaged in providing stock newsletters on various hot penny stocks on a regular basis. Our instant stock news on Major Gainers, small cap penny stocks and various other stocks, guides investors in making the wise stock market investments decision. In order to get update to the markets, we would advise you sign up to our free newsletters. You can become leader in stock market by keeping track of the daily activity.

Disclaimer
The assembled information disseminated by Bestdamnpennystocks.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Bestdamnpennystocks.com does expect that investors will buy and sell securities based on information assembled and presented in Bestdamnpennystocks.com. PLEASE always do your own due diligence, and consult your financial advisor.